Below is a brief video excerpt from www.thehighwire.com

(click the image of Del & Dr. Bartlett below for the 2 minute video excerpt) 

‘SILVER BULLET’ PROTOCOL FOR COVID VALIDATED TWO YEARS AFTER ATTACKED

The focus is on using Biaxin (clarithromycin) by Dr. Richard Bartlett as a treatment for lung infections. This was used in conjunction with budesonide to save lives and prevent the need for ventilators.

In many vaccine-injured and long-haul covid sufferers, Biaxin may see the continued value. It is an antibiotic but has anti-inflammatory properties and lowers many cytokines associated with COVID, long-haul, and possibly the spike protein.

My partner at Harvard Medical School, Clement L. Trempe, and I wrote a patent on using Biaxin and tetracyclines to treat a wide range of stealth infections, including Lyme disease and chlamydia pneumoniae.

Here is the link to that patent for those interested in a deeper dive into the treatment modes of action.

https://patents.google.com/patent/WO2013040206A1/en

Here are some links about people who died suddenly or unexpected became ill.

By Children’s Health Defense

The Health and Resources Service Administration (HRSA) vaccine injury claims report, updated monthly, shows one $2,019.55 payment for anaphylaxis and two payments — $1,582.65 and $1,032.69 — for myocarditis.

The payments were made through HRSA’s Countermeasures Injury Compensation Program (CICP).

The CICP was established under the Public Readiness and Emergency Preparedness (PREP) Act, which protects pharmaceutical companies from liability for injuries sustained from “countermeasures,” such as vaccines and medications, administered during a public health emergency.

Since 2010, when it approved its first claim, the program has compensated a total of 33 claims for vaccine injuries — but these are the first awards for COVID-19 vaccines.

“These long-awaited awards were overdue, highly anticipated and speculated upon,” said Kim Mack Rosenberg, acting general counsel for Children’s Health Defense (CHD). “What is remarkable is that less than $5,000 was paid — total. This is a tragedy that highlights the severe limitations of the program.”

CHD Acting President Laura Bono called the payouts for myocarditis “insulting,” given that mortality rates increase to 50% within five years of diagnosis.

Bono said:

“The CICP is a pathetic, government-run program that gives complete liability protection to the very industries profiting from the COVID vaccine or product. While victims linger with their injuries, paying out-of-pocket for expenses, or at worst die, the industries run to the bank.”

Since the start of the pandemic, people claiming injuries related to COVID-19 vaccines and other countermeasures submitted 11,425 requests for compensation.

Of those, only 19 have been declared eligible for compensation and are undergoing a “medical benefits review” to determine payment.

The anaphylaxis case had been pending medical benefits review since the fall of 2021, and the two myocarditis cases had been pending review since January.

During the medical benefits review, HRSA determines any costs remaining after insurance, workers’ comp, disability or other reimbursements or payments.

Wayne Rohde, an expert in vaccine injury compensation, wrote on his Substack that given the “18+ months to review previous medical benefits that may have been awarded to the injured party [the anaphylaxis case], this process tells me it was a major injury that resulted in very large medical bills.”

Myocarditis is a serious condition that also requires a lot of medical attention, Rohde said.

To date, there have been 1,541,275 reports of adverse events following COVID-19 vaccination submitted to the Vaccine Adverse Event Reporting System (VAERS).

By Peter A. McCullough, MD, MPH

I am routinely asked: why are so many people who took the COVID-19 vaccines apparently fine while others are suffering heart damage, strokes, blood clots and are ending up disabled or dead? It has been suspected for many months that there may be variations in vaccine lots or batches that could partially explain these observations. In other words, not everyone is getting the same dose of mRNA.

Under Emergency Use Authorization, the vaccine companies and their subcontractors do not have any inspections of the final filled and finished vials. This is unprecedented for a widely used product of any type. It is possible that lipid nanoparticles aggregate in suspension and so some batches may contain more mRNA than others. Likewise, since lot size has varied over time, it is possible that contaminants from the manufacturing process may be concentrated in some smaller lots compared to larger ones. Finally, there may be product transport, storage, and use factors that denature mRNA including heating, air injected into vials, and multiple needles dipped into the suspension.

The contaminant issue came to light as Japan returned millions of doses when visible debris was seen in the bottom of the vials. Additionally, since metallic beads are used by the biodefense contactors, it is possible that smaller initial lots could have had magnetic debris that explained “magnetism” in the arm where the shot was given as reported early in the vaccine campaign.

A report from Schmeling and coworkers using Pfizer BNT162b2 mRNA COVID-19 vaccine found that 71% of serious adverse events came from 4.2% of doses (high risk batches) conversely <1% of these events came from 32.1% of doses (low risk batches). The variation explained for the high and moderate risk batches was 78 and 89%, respectively. Thus as more doses were given out of those vials, the greater the number of side effects were reported. This means that the majority of risk is in the shot and not the person who received it.

Over 100,000,000 visits as of today

Dr. Ana Maria Mihalcea, MD, PhD reports that darkfield like blood microscopy show definite proof that EDTA chelation affects rapid positive changes in blood.

Dr. Mihalcea states:

“These structures in the blood, which I call Hydrogel/ Graphene, can be cleared effectively and rapidly.

I have advocated for the use of EDTA Chelation intravenously because I saw rapid and substantial changes in the blood.

My practice is an anti-aging clinic, so I additionally use peptides like Epithalon, which lengthens telomeres and repairs DNA to help reverse the accelerated aging symptoms often seen these days. The Vitamin C infusions and Epithalon are not necessary to use for decontamination of the blood, but they significantly help improve symptoms.

In addition to objective improvement of the blood, all patients had symptom improvement.”

To read the entire post from Dr. Mihalcea, click on the image above.